WHO to meet on Oct 26 to consider Covaxin's emergency listing | Latest News India - Hindustan Times
close_game
close_game

WHO to meet on Oct 26 to consider Covaxin's emergency listing

Written by Shubhangi Gupta | Edited by Poulomi Ghosh, Hindustan Times, New Delhi
Oct 17, 2021 10:50 PM IST

With this recent development, India can now expect the Emergency Use approval for Covaxin by the last week of October.

India may have to wait slightly longer for the World Health Organisation (WHO) to grant the Emergency use approval to Bharat Biotech's Covid-19 vaccine Covaxin. Taking to Twitter, WHO chief scientist Soumya Swaminathan informed on Sunday that the technical advisory group, involved in examining the vaccine, will meet on October 26 to consider the Emergency use listing (EUL) for Covaxin. She further stated that the world health body is working closely with the Hyderabad-based Bharat Biotech to complete the formalities.

On October 5, the world health body extended giving the EUL to Covaxin by a week. (File photo)
On October 5, the world health body extended giving the EUL to Covaxin by a week. (File photo)

“The technical advisory group will meet on Oct 26th to consider EUL (Emergency use listing) for Covaxin. WHO has been working closely with BharatBiotech to complete the dossier. Our goal is to have a broad portfolio of vaccines approved for emergency use & to expand access to populations everywhere,” Dr Soumya Swaminathan tweeted.

Hindustan Times - your fastest source for breaking news! Read now.

On WHO's request, Bharat Biotech submitted additional information on the vaccine on September 27. On October 5, the world health body extended giving the EUL to Covaxin by a week. With this recent development, India can now expect the Emergency Use approval for the Covid-19 vaccine by the last week of October.

The Emergency Use Listing process - done by WHO and the Technical Advisory Group of independent experts - is centred on determining if a manufactured product (e.g. a vaccine) is quality-assured, safe and effective, WHO informed in a tweet earlier.

The indigenously developed Bharat Biotech's Covaxin is one of the six vaccines that have received emergency use authorisation from India's Drug Regulator and is being used in the nationwide anti-COVID-19 inoculation programme along with Covishield and Sputnik V. It was developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR) and the National Institute of Virology (NIV).

Unveiling Elections 2024: The Big Picture', a fresh segment in HT's talk show 'The Interview with Kumkum Chadha', where leaders across the political spectrum discuss the upcoming general elections. Watch now!

Get Current Updates on India News, Election 2024, Mukhtar Ansari Death News Live, Bihar Board 10th Result 2024 Live along with Latest News and Top Headlines from India and around the world.
SHARE THIS ARTICLE ON
Share this article
SHARE
Story Saved
Live Score
OPEN APP
Saved Articles
Following
My Reads
Sign out
New Delhi 0C
Friday, March 29, 2024
Start 14 Days Free Trial Subscribe Now
Follow Us On